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Krill oil represents an important alternative natural source of omega-3 (ω-3)
polyunsaturated fatty acids (PUFAs). Considering the beneficial health effects of these
essential fatty acids, particularly in various disorders including cancer, cardiovascular, and
inflammation diseases, it is of paramount importance to gain insight into the digestibility
of krill oil. In this work, we study the fate of krill oil-in-water emulsion, stabilized by
sodium caseinate, during lipolysis by coupling time-resolved synchrotron small-angle
X-ray scattering (SAXS) to flow-through lipolysis model. For gaining further insight into
the effect of ω-3 PUFA-containing oil type on the dynamic structural features occurring
during lipolysis, two additional astaxanthin oil-in-water emulsions, stabilized using either
sodium caseinate or citrem, were subjected to lipolysis under identical experimental
conditions. In addition to the difference in lipid composition in both oils, ω-3 PUFAs
in astaxanthin oil, similar to fish oil, exist in the form of triacylglycerols; whereas most
of those in krill oil are bound to phospholipids. SAXS showed the formation of highly
ordered nanostructures on exposure of these food emulsions to the lipolysis medium:
the detection of a biphasic feature of coexisting inverse hexagonal (H2) and lamellar (Lα)
liquid crystalline phases in the digested krill oil droplets’ interiors, as compared to a neat
Lα phase in the digested astaxanthin oil droplets. We discuss the dynamic phase behavior
and describe the suggested important role of these phases in facilitating the delivery of
nutrients throughout the body. In addition, the potential implication in the development
of food and drug nanocarriers is briefly described.
Keywords: astaxanthin oil, krill oil, lamellar and inverse hexagonal liquid crystalline phases, lipolysis, omega-3
polyunsaturated fatty acids, synchrotron small angle X-ray scattering
INTRODUCTION
Fish (FO) and krill (KO) oils are important natural sources of omega-3 (ω-3) polyunsaturated fatty
acids (PUFAs). Mackerel, salmon, and herring are the main sources of marine ω-3 PUFAs; whereas
KO is extracted from the Antarctic shrimp-like crustacean Euphausia superba. This Krill lives in
the deep ocean and itself is a food source for many bigger marine animals (e.g., whales and seals)
(Fragakis, 2008; Atkinson et al., 2009). KO is Generally Recognized as Safe (GRAS) by the American
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Food and Drug Administration (FDA), and secures an
unconventional food source for ω-3 PUFAs. It is rich in
ω-3 PUFA-containing phospholipids (Ramprasath et al., 2013).
In addition, it is rich in different compounds that secure its
protection against oxidation such as vitamins A and E, and
the carotenoid astaxanthin that has typical concentrations of
200–400 ppm (Kolakowska et al., 1994; Atkinson et al., 2009;
Ramprasath et al., 2013). Figure 1A presents the molecular
structure of astaxanthin. The most abundant phospholipid in
KO is phosphatidylcholine (PC), and the deep red color of this
oil is attributed to the presence of astaxanthin. In addition to
phospholipids (19–81%) and triacylglycerols (12–30%), KO
contains the following amphiphilic compounds: free fatty acids
(FFAs), cholesterol, and diacylglycerols. The attractiveness of KO
as an important source of natural nutritional compounds relies
also on the published preclinical and clinical investigations on
its safety, well-tolerance, and lack of adverse effects (Ruggiero-
Lopez et al., 1994; Sampalis et al., 2003; Bunea et al., 2004;
Deutsch, 2007; Maki et al., 2009).
The dietary intake of FO and KO is important and associated
with promoting positive health effects. For instance, it was
found that FO intake lowers the blood lipid concentration and
reduces systolic blood pressure (Araujo et al., 2014); whereas KO
promotes lipid metabolism, controls hyperlipidemia, and offers
a greater potential than other marine oils, owing particularly
to its richness with phospholipids. It was found that KO exerts
anti-inflammatory and hypolipidemic effects (Ulven and Holven,
2015; Ristic´-Medic´ et al., 2018). It is also more effective at
lowering cholesterol levels than FO (Massrieh, 2008). It was
also recently reported using randomized controlled human trials
with 36 healthy adults that this oil intake is associated with a
significant reduction in blood glucose concentration (Rundblad
et al., 2018). Another important finding with potential health
implications, as recently suggested by Bruheim et al. (2015), is
the effectiveness of KO in the treatment of obesity, which is one
of the major modern health problems.
As illustrated in Figures 1B,C, an important difference in the
ω-3 PUFA composition between FO and KO is the presence
of a large fraction (30–65%) of fatty acids conjugated to the
glycerol moieties of phospholipids in KO; whereas the rest exists
in the form of triacylglycerols (Ramprasath et al., 2015). In FO,
ω-3 PUFAs are mainly present in the form of triacylglycerols
(Ramprasath et al., 2015; Ulven and Holven, 2015). It was
proposed that binding ω-3 PUFAs to phospholipids facilitates
their incorporation into cell membranes (Bunea et al., 2004; Maki
et al., 2009; Schuchardt et al., 2011; Ulven et al., 2011; Ramprasath
et al., 2013). In addition, it provides self-assembling properties
to KO, enhances the bioavailability, and improves the oxidative
stability as compared to FO (Henna Lu et al., 2011; Ulven et al.,
2011; Wu et al., 2016).
Abbreviations: AO, astaxanthin; DLS, dynamic light scattering; DHA,
docosahexaenoic acid (22:6, n-3); EPA, eicosapentaenoic acid (20:5, n-3);
FDA, American Food and Drug Administration; FFAs, free fatty acids; FO, fish
oil; KO, krill oil; GRAS, Generally Recognized as Safe; ω-3 PUFAs, omega-3
polyunsaturated fatty acids; PBS, phosphate buffer; PC, phosphatidylcholine; PDI,
polydispersity index; SAXS, small angle X-ray scattering.
FIGURE 1 | (A) The molecular structure of the natural fat-soluble antioxidant
astaxanthin that provides KO with the blood reddish color. (B,C) illustrate the
main difference in the ω-3 PUFA composition between FO and KO. In (B), an
example on the typical presence of the ω-3 PUFAs docosahexaenoic acid
(DHA; 22:6 n-3) and eicosapentaenoic acid (EPA; 20:5 n-3) in the form of
triacylglycerols is given; whereas (C) shows that these ω-3 PUFAs are typically
conjugated to the glycerol moieties of phospholipids in KO. These molecular
structures were drawn with ChemBioDraw Ultra version 12 (PerkinElmer
Informatics, Waltham, MA, USA).
ω-3 PUFAs in KO and FO, particularly eicosapentaenoic
(EPA; 20:5, n-3) and docosahexaenoic (DHA; 22:6, n-3) acids,
are important nutritional compounds and have beneficial health
effects in various disorders in humans including inflammation
diseases, cancer, and cardiovascular diseases, among others
(Bradberry and Hilleman, 2013; Wang et al., 2014; Richter et al.,
2016; Yaghmur et al., 2017). EPA and DHA should be integrated
in our diet as humans cannot synthesize these essential fatty
acids or produce their precursor α-linolenic acid (Davidson et al.,
2012; Swanson et al., 2012; Kohler et al., 2015; Ramprasath
et al., 2015; Mori, 2018). As compared to the triacylglycerol form
of EPA and DHA in FO, the superior bioavailability of KO is
most likely attributed to the presence of these essential acids
in the phospholipid-enriched form: 70 % of EPA and DHA are
bound to phospholipids in KO (Bunea et al., 2004; Kutzner et al.,
2017). It was suggested that the amphiphilic compounds (mainly
phospholipids) in KO play an important role in enhancing the
absorption and intestinal digestion (Davidson et al., 2012; van
Hoogevest and Wendel, 2014; Ulven and Holven, 2015).
Similar to FO, recent reports focus on improving further the
bioavailability and enhancing the oxidation stability of KO by its
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solubilization in food-grade lipid nanocarriers, mainly emulsions
and self-emulsifying drug delivery systems (Neslihan Gursoy and
Benita, 2004; Salminen et al., 2013; Bonaterra et al., 2017; Seto
et al., 2018). However, the number of studies is still limited
in the literature and further investigations are still needed to
fully characterize these nanocarriers and gain further insight
into their colloidal and oxidation stabilities under different
experimental conditions.
Previous studies reported that emulsification of FO prior
to digestion enhances the bioavailability and absorption of
ω-3 PUFAs including EPA and DHA as compared to the
corresponding bulk (non-dispersed) oils (Armand et al., 1994;
Borel et al., 2001). In case of colloidal dispersions including food
emulsions, the competitive adsorption behavior in the stomach
among the emulsified oils, lipids, and other food bioactive
molecules such as enzymes, proteins, and polysaccharides is
associated with the tendency of substances with higher surface
activity to be accommodated at the interface (McClements et al.,
2009). The triglyceride composition was also found to affect
the size distribution, the surface charge, and the nanostructure
of digested colloidal dispersions (Zhang et al., 2015). In these
investigations, an important aspect that should be taken into
account is related to the dynamic changes in the structural and
morphological features, size characteristics, and composition of
food emulsion droplets, and related colloidal nanoparticles (e.g.,
liposomes, cubosomes, and hexosomes), on their way through
the gastro intestinal tract (Zhang and McClements, 2018).
In previous reports, the nanostructure formation during
the digestion of triglyceride-based emulsions including milk,
mayonnaise, and a model triolein-in-water emulsion was
investigated (Patton and Carey, 1979; Salentinig et al., 2011,
2015a, 2017; Marze et al., 2015; Salentinig, 2019; Vithani et al.,
2019). The major part of lipid digestion takes place in the small
intestine by pancreatic lipase and various cofactors (colipase,
bile salts, and calcium) at typical pH in the range of 6.0–
8.0 (Golding and Wooster, 2010). In this process, pancreatic
lipase adsorbs onto the emulsion droplets and stereospecifically
hydrolyzes the two outer ester bonds of the triglycerides, denoted
as sn-1 and sn-3, resulting in the generation of the sn-2
monoglyceride and the corresponding free fatty acids (FFAs)
(Salentinig et al., 2015b). This leads to structural alterations
in the emulsified oil droplets’ interiors: the occurrence of
colloidal objects with self-assembled interiors including inverse
non-lamellar liquid crystalline structures and micellar phases
(Salentinig et al., 2011, 2015a, 2017), similar to the nanostructural
features of cubosomes, hexosomes, and other related colloidal
nanodispersions (Yaghmur and Glatter, 2009; Azmi et al., 2015;
Meli et al., 2015; Yaghmur et al., 2017, 2019; Shao et al.,
2018). It was proposed that these nano-self-assemblies act as
structured nanocarriers for facilitating transport and absorption
of poorly water-soluble nutrients (Huang et al., 2010; Nik
et al., 2011; Luo et al., 2012; Teng et al., 2013; Guttoff et al.,
2015; Prajapati et al., 2019a). In recent studies, there is a
growing interest in the development of such nanocarriers,
mainly cubosomes and hexosomes, for drug-delivery and bio-
imaging applications (Nilsson et al., 2013; Azmi et al., 2015,
2016, 2018; Meli et al., 2015; Wibroe et al., 2015; Gontsarik
et al., 2016, 2019; Angelova et al., 2017; Bor et al., 2019;
Prajapati et al., 2019b). In the development of these non-
lamellar liquid crystalline nanoparticles, the most investigated
monounsaturated monoglyceride is monoolein (Nakano et al.,
2002; Yaghmur and Glatter, 2009). The possible use of new
ω-3 PUFA monoglycerides as main lipid constituents in the
development of these nanocarriers for the delivery of therapeutic
agents, nutraceuticals, and their combinations was recently
discussed (Yaghmur et al., 2017; Shao et al., 2018).
In the present work, it was the main interest to combine
synchrotron small-angle X-ray scattering (SAXS) with flow
through lipolysis model for investigating the colloidal behavior
of krill oil (KO) and astaxanthin oil (AO) emulsions during
digestion. Herein, it should be emphasized that synchrotron
SAXS is a powerful tool for dynamic structural investigations
and provides important information on structural alterations
in these emulsion droplets during the digestion process. It
is also important to emphasize that this research on the in
situ dynamic formation of lamellar and non-lamellar structures
during digestion of food emulsions is still in its infancy and there
is an urgent need for further fundamental research studies to
translate the experimental findings to relevant future food and
pharmaceutical applications. Figure 2A schematically illustrate
the applied set-up. In contrast to KO, ω-3 PUFAs in AO, which
is produced from krill harvested in the antarctic ocean, are
mainly present in the form of triacylglycerols. Hence, KO will
be mainly digested by phospholipase and AO by pancreatic
lipase in the small intestine. This study aims at comparing
the digestion behavior of these two important sources of ω-
3 PUFAs and linking the generated nanostructures to their
main lipid constituents. These investigations are important for
gaining insight into the dynamic structural transitions occurring
due to variations in the lipid composition of digested KO and
AO emulsion droplets during lipolysis. As lipase is a surface-
active enzyme and needs to access the lipid-water interface
for initiating digestion, the stabilizer type may have a major
impact on this process. To further shed light on the effect of the
stabilizer type on digestion, we compared the dynamic structural
features of AO emulsion stabilized by sodium caseinate from
bovine milk with that stabilized using the anionic food-grade
emulsifier citrem.
Taking into account the health beneficial effects of ω-
3 PUFAs, the lipolysis-mediated generation of nanoparticles
enveloping an internal liquid crystalline nanostructure, similar
to cubosomes, hexosomes, and related nanoparticles during the
digestion of model ω-3 PUFA emulsions may have implications
in relation to soft self-assembled nanocarrier design for delivery
of ω-3 PUFA alone or in combination with drugs or other
nutraceuticals. We should bear in mind that the potential
translation of the experimental findings to future functional
food and drug delivery applications requires combining SAXS
investigations with relevant biological evaluations, and further
research efforts on the influence of the digestive conditions on
size characteristics and morphological features of the generated
particles. The implications and potential future applications
of such colloidal nanocarriers for drug and food delivery
applications are discussed in a recent review (Salentinig, 2019).
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 3 December 2019 | Volume 7 | Article 384
Yaghmur et al. Lipolysis-Triggered Dynamic Structural Features
FIGURE 2 | (A) Schematic illustration of the flow-through lipolysis model
combined with synchrotron SAXS for investigating the colloidal behavior of krill
oil (KO) and astaxanthin oil (AO) emulsions during in vitro digestion. In this
set-up, the lipolysis vessel was connected to a flow-through 1.5mm quartz
capillary and pH was maintained at 6.5. SAXS findings indicated the formation
of liquid crystalline nanostructures on exposure of these ω-3 PUFA-containing
emulsions to the lipolysis medium. (B) Pictures taken for the three investigated
samples (S1–S3) after 3 months of preparation and storage at room
temperature.
MATERIALS AND METHODS
Materials
Krill (KO, SuperbaTM 2) and astaxanthin (AO, QrillTM) oils
were kindly donated by Aker Biomarine Manufacturing LLC in
Houston (Texas, US) and Aker biomarine Antarctic (Lysaker,
Norway), respectively. According to the supplier’s specifications,
the total phospholipid content of KO was about 48.0 wt%
comprising phosphatidylcholine (about 44.0 wt%) and choline
(about 6.0 wt%). It has a total ω-3 PUFA content of 24.2 wt%
including EPA (14.8 wt%) and DHA (6.7 wt%) (Table 1). In
addition, it contains a residual amount of omega-6 (ω-6) fatty
acids (about 1.0 wt%) and about 287 (µg/g oil) astaxanthin.
AO contains a greater concentration of astaxanthin (≥750µg/g
oil), and consists of about 16.8 wt% ω-3 PUFAs, and about
0.5 wt% free fatty acids (FFAs) (Table 1). Among ω-3 PUFAs,
TABLE 1 | Average composition of astaxanthin oil (AO) and Krill oil (KO).
Content AO KO
Lipids (wt%) (wt%)
Total ω-3 PUFAs 16.8 24.2
EPA 4.3 14.8
DHA 2.8 6.7
Total phospholipids 48.0
Phosphatidylcholine (PC) <1.0 44.0
Choline 6.0
Total ω-6 PUFAs <3
Triacylglycerols 96.0 <34
Diacylglycerols 2.0
Monoacylglycerols <1.0
Free fatty acids (FFAs) 0.5
Total neutral lipid 99.8
Astaxanthin ≥750µg/g oil 287µg/g oil
AO contains about 2.8 wt% DHA and about 4.3 wt% EPA
(Table 1). According to the supplier’s specifications, ω-3 PUFAs
exist in the form of triacylglycerols in AO. The food emulsifier
sodium caseinate from bovine milk, and sodium azide (SA)
that was used as an antimicrobial preservative were purchased
from Sigma-Aldrich (St. Louis, USA). Grinsted R© citrem LR10,
a commercial anionic food emulsifier made from sunflower oil,
was received as a gift fromDanisco A/S (Copenhagen, Denmark).
It consists of citric acid esters of mono- and di-glycerides,
where oleic acid content is 79.1% of its total fatty acid content
(Amara et al., 2014). For producing KO and AO emulsions,
67mM phosphate buffer (PBS) at pH 7.40 was prepared by
using Dulbecco’s saline tablets purchased from Sigma Aldrich (St.
Louis, Missouri, USA). In the in vitro digestion study, pH was
adjusted to 6.5 using either 0.2MNaOH or 0.2MHCl (p.a. grade,
Sigma-Aldrich, St. Louis, MO, USA). Pancreatin from porcine
pancreas (8× USP grade pancreatin activity) was purchased
from Sigma-Aldrich (St. Louis, MO, USA). It is a commercial
mixture of digestive enzymes produced by the exocrine cells of
the pancreas and contains components such as lipase, amylase,
trypsin, ribonuclease, and protease (Salentinig et al., 2017). For
preparing the buffer, Milli-Q water was collected from Millipore
Direct-Q3 UV system (Billerica, MA, USA). All materials were
used without further purification.
Preparation of KO and AO Emulsions
Three oil-in-water (O/W) emulsions stabilized using sodium
caseinate (samples S1 and S2) or citrem (sample S3) were
prepared by means of ultrasonication (Ultrasonic Processor
Qsonica 500, Qsonica LLC, Newtown, CT, USA) for 5min
in pulse mode (5 s pulses interrupted by 2 s breaks) at 30%
of its maximum power (500W). For the preparation of these
samples, the solutions of binary mixtures of KO/sodium
caseinate, AO/sodium caseinate, and AO/citrem were prepared
at room temperature at a fixed KO (or AO)/sodium caseinate
(or citrem) weight ratio of 4:1 and dispersed in excess PBS
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with pH of 7.4. They were composed of 5.0 wt% binary
oil/emulsifier mixture of KO/sodium caseinate (sample S1),
AO/sodium caseinate (sample S2), and AO/citrem (sample
S3) and a small amount of sodium azide (0.01 wt%), that
was used as an antimicrobial preservative. In addition, they
were flushed with nitrogen gas for 2min, capped, covered by
aluminum foil, and incubated at room temperature prior to the
planned investigations.
Zeta Potential and Droplet Size
Measurements
The zeta potentials and the mean hydrodynamic diameters
were measured using Zetasizer Nano ZS (Malvern Instruments,
Worcestershire, UK) equipped with a 633 nm laser and 173◦
detection optics. The measurements were performed at room
temperature on samples diluted 100x in 67mM PBS, and data
acquisition and analysis were conducted using Malvern DTS
v.6.34 software (Malvern instruments, Worcestershire, UK). For
the viscosity and refractive index, the values of pure water
were used.
Lipolysis Model
The in vitro digestion was studied using online synchrotron
SAXS similar to our previous studies (Salentinig et al., 2011,
2015a, 2017). The digestion reaction was performed at 37◦C in
a thermostated 20mL reaction vessel under constant magnetic
stirring. This vessel was connected to a flow-through 1.5mm
quartz capillary usingHPLC tubing and pHwasmaintained at 6.5
in all experiments with an autotitrator (Titrando 906, Metrohm
AG, Herisau, Switzerland). In the small-angle X-ray scattering
(SAXS) set-up, the capillary was placed in the capillary holder
and the digestion medium was circulated using a peristaltic
pump, while recording SAXS in real time for monitoring
the evolution of the self-assembled nanostructure during the
sample digestion.
Five milliliters of sample (emulsion) was mixed with 4mL
of buffer at pH 6.5 and circulated during the real-time SAXS
measurements. In this study, the pancreatin solution was
prepared by mixing 5 g pancreatin extract into 20mL of buffer
at pH 6.5 and stirring using a magnetic stirrer for 30min
at 4◦C. The mixture was then centrifuged at 5,000 xg for
20min at 4◦C, and the supernatant filled into an 1mL syringe.
The digestion reaction was started by using a syringe pump
(neMesys, centoni GmbH, Korbußen, Germany) for remotely
adding 1mL of the prepared pancreatin solution with a speed
of approximately 0.2 mL/s. Then, the pH-stat titrated the
digestion mixture with 0.2M NaOH solution in order to
maintain pH at 6.5.
Synchrotron Small-Angle X-Ray Scattering
(SAXS)
For gaining insight into the effect of in vitro digestion on the
structural features of the three prepared oil-in-water emulsions,
the lipolysis model was combined with synchrotron SAXS.
The measurements were performed on the cSAXS beamline at
the Swiss Light Source, Paul Scherrer Institute (PSI) (Villigen,
Switzerland). An X-ray beam having a wavelength of 1.107 Å at
X-ray energy of 11.2 keV was used. The sample-detector distance
was 2152.4mm and the scattering vector, q, covered a range of
0.1–5.0 nm−1 (q = 4pi /λ sinθ , where λ is the wavelength and
2θ is the scattering angle). All experiments were done at 37◦C
(±0.1◦C). The 2D SAXS patterns were acquired over 3,500 s with
an exposure time of 1 s with 9 s delay between frames, using an
Pilatus 2M detector (in-house prototype) with an active area of
254 × 289 mm2 and a pixel size of 172 x 172 µm2. The 2D
scattering frames were radially integrated into one-dimensional
(1-D) curves and plotted as a function of relative intensity I(q) vs.
q. After subtracting the background scattering (PBS buffer), all
Bragg peaks were fitted by Lorentzian distributions. The lattice
parameter (a) and d-spacing of the inverse hexagonal (H2) and
lamellar (La) liquid crystalline nanostructures, respectively, were
gleaned from SAXS reflections.
RESULTS AND DISCUSSION
Size and Surface Charge Characteristics of
KO and AO Emulsions
The mean droplet diameters for sodium caseinate-stabilized
KO and AO emulsions (samples S1 and S2) were 294.6 ± 22.7
and 296.8 ± 25.8 nm, respectively, and consistent with those
previously reported for KO dispersions prepared in the presence
of lysolecithin, glycerin, and hydroxypropyl methylcellulose
(Seto et al., 2018). The polydispersity indices (PDIs) for
both samples were 0.26 ± 0.08 and 0.20 ± 0.11, respectively
(Table 2). The presence of marine phospholipids in KO, and
natural emulsifiers including diacylgylcerols, monoacylglycerols
(monoglycerides), phospholipids, and FFAs in AO improves the
emulsifying properties of these oils, and enhances, therefore,
the colloidal stabilization of the prepared oil-in-water (O/W)
emulsions. For citrem-stabilized AO emulsion (sample S3), the
use of the anionic emulsifier citrem instead of sodium caseinate
was associated with a decrease in the mean droplet size and PDI
to 226.4± 7.9 nm and 0.152± 0.07, respectively. The droplets in
the three samples were negatively charged based on zeta potential
measurements (Table 2). Clearly, the replacement of sodium
caseinate by citrem led to a decrease in zeta potential from
−19.85 ± 1.49 to −31.8 ± 1.86mV owing to the adsorption of
the negatively charged citrem molecules into the outer surfaces
of AO droplets. In literature, it was reported that a good colloidal
stability for ionic aqueous dispersions including emulsions can
be achieved in the presence of single charged emulsifiers such as
citrem on dispersing droplets with zeta potential values around
±30mV in excess water (Honary and Zahir, 2013). In addition
to its use as stabilizer with an anti-oxidative property for various
food emulsions (Gudipati et al., 2010; Berton et al., 2011),
citrem is attractive for use as a safe emulsifier for stabilizing
lamellar and non-lamellar liquid crystalline nanoparticles owing
to its hemocompatiblity and poor activation of the complement
system (Nilsson et al., 2012; Hedegaard et al., 2013; Wibroe et al.,
2015; Prajapati et al., 2018). In our study, the three investigated
samples were visually inspected and found to be colloidally stable
at room temperature for at least 3 months after preparation, see
images in Figure 2B.
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TABLE 2 | Size characteristics and zeta potential values for KO-in-water and
AO-in-water emulsions stabilized by using either sodium caseinate from bovine
milk or citrem.
Sample ζ-potential
(mV)
Mean size
(diameter, nm)
PDI
S1: KO-in-water
emulsiona
−9.29 ±
0.41mV
294.6 ± 22.7 0.26 ± 0.08
S2: AO-in-water
emulsiona
−19.85 ±
1.49mV
296.8 ± 25.8 0.20 ± 0.11
S3: AO-in-water
emulsionb
−31.8 ±
1.86mV
226.4 ± 7.9 0.15 ± 0.07
These samples were prepared using PBS at pH 7.4.
aThe emulsions (samples S1 and S2) were stabilized using sodium caseinate at KO (or
AO)/sodium caseinate weight ratio of 4:1.
bThe emulsion (samples S3) was stabilized using citrem at AO/citrem weight ratio of 4:1.
Digestion Triggered Dynamic Structural
Alterations in KO and AO Emulsions
Synchrotron SAXS coupled with flow-through lipolysis model
was used to gain insight into the fate of KO and AO
emulsion droplets under simulated conditions of the small
intestine, which is considered the main site for lipid digestion
that leads to structural alterations or generation of nano-self-
assemblies (Salentinig et al., 2015a, 2017; Salentinig, 2019;
Vithani et al., 2019). At pH of 6.5, where pancreatic lipase
has its maximum activity, the digestion-triggering dynamic
structural alterations in the three KO andAO emulsions (samples
S1–S3) were investigated. Figure 3 presents the time-resolved
SAXS intensity profiles for the digested KO and OA emulsions.
Before the addition of pancreatin extract containing the lipase,
a weak reflection at q of about 0.83 nm−1 can be observed
in the SAXS pattern of the KO emulsion (Figure 3A), that
is absent in the AO systems (Figures 3B,C). This reflection
may arise from the formation of traces of multi-lamellar
structures during emulsification of KO that contains up to 48.0
wt% phospholipids. Representative SAXS diffraction patterns
at different elapsed times of lipolysis are also presented in
Figure 4. Before the addition of pancreatin extract, the detected
upturn of the SAXS patterns of the three investigated emulsions,
as shown in Figure 3, at relatively low q values is most
likely attributed to scattering from emulsion droplets with
dimensions larger than the resolution of the SAXS setup.
For these emulsions, it was evident from the SAXS patterns
presented in Figures 3, 4 that KO and AO digestion was
associated with the appearance of either a biphasic feature of
a lamellar (Lα) phase coexisting with an inverse hexagonal
(H2) phase (Figures 3A, 4A) or a neat Lα phase (Figures 3B,C,
4B,C). Depending on the lipid structure (e.g., unsaturation
degree, acyl chain length, and structure of polar headgroup)
and composition, the trends in appearance and evolving
behavior of the lyotropic lamellar and non-lamellar liquid
crystalline phases during lipolysis in these emulsion droplets
were consistent with previous investigations on the in situ
lipolysis of triolein emulsions, milk, and triglyceride-containing
emulsified food products such as mayonnaise (Salentinig et al.,
2011, 2015a, 2017) (Table 2). The rapid occurrence of self-
FIGURE 3 | SAXS patterns for three in situ digested KO emulsion (A), and AO
emulsions stabilized by using sodium caseinate (B) and citrem (C). In (A–C),
the time-resolved SAXS experiments for about 49, 50, and 57min,
respectively, were conducted on the three investigated KO and AO emulsions
(samples S1–S3, see Table 2) at 37◦C. The green SAXS patterns in (A,B) are
taken for the two KO (A) and AO (B) emulsions stabilized by using sodium
caseinate emulsions before the addition of pancreatin extract containing the
lipase. For the in situ SAXS experiments, the first SAXS pattern was plotted
20 s after addition of the pancreatin extract, and then SAXS patterns were
plotted every 10 s during the lipolysis process.
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FIGURE 4 | Selected SAXS patterns are presented at different elapsed times
for the three in situ digested KO emulsion (A), and AO emulsions stabilized by
using sodium caseinate (B) and citrem (C). The Bragg peaks are represented
with red and black colors for the corresponding Miller indices of the inverse
hexagonal (H2) and lamellar (Lα) phases, respectively. The intensities in (A–C)
have been shifted by a constant arbitrary factor for better visibility.
assembled interiors in these KO and AO emulsion droplets
(Figure 3) is attributed to the lipolysis-mediated generation of
amphiphilic lipids and the involved fast molecular re-distribution
and alterations in the lipid composition. Referring back to
the lipolysis products, the adsorption of pancreatic lipase into
the emulsion droplets’ surfaces enhances the hydrolysis of
triglycerides resulting in monoglycerides, diglycerides, and FFAs.
Depending on molecular structure, ionic strength, temperature,
and pH, these amphiphilic compounds and their combinations
have the propensity to adopt lamellar and non-lamellar liquid
crystalline phases on exposure to excess water (Nakano et al.,
2002; de Campo et al., 2004; Yaghmur et al., 2005, 2017;
Yaghmur and Glatter, 2009; Azmi et al., 2016; Gontsarik et al.,
2016, 2018, 2019; Angelova et al., 2017). Thus, the lipolysis-
triggered transition from emulsified oil droplets to lamellar or
non-lamellar liquid crystalline interiors (Figure 3) was affected
by the type of oil and attributed to the self-assembly of the
digestion generated amphiphilic lipids in the lipolysis medium.
The evolved scattering curves resembled those typically reported
for liposomes, cubosomes, hexosomes, amongst others (Nakano
et al., 2002; de Campo et al., 2004; Yaghmur et al., 2005;
Yaghmur and Glatter, 2009; Azmi et al., 2016; Angelova et al.,
2017; Gontsarik et al., 2018). Taking into account the suggested
important role of these produced self-assembled nanostructures
in facilitating the delivery and distribution of nutritional
compounds throughout the body (Salentinig et al., 2011, 2015a,
2017; Salentinig, 2019; Vithani et al., 2019), there is a growing
interest in exploring the implications for future development of
advanced functional food and drug nanocarriers (Azmi et al.,
2015; Angelova et al., 2017; Shao et al., 2018; Bor et al., 2019;
Yaghmur, 2019).
Referring again to Figures 3A, 4A, the fast molecular re-
distribution and self-assembly of the generated amphiphilic
lipolysis products in the emulsified KO droplets led first to
the appearance of the H2 phase. After about 80 s, the first
order reflection (100) of this phase started to be visible as a
very weak peak at q-value of about 1.01 nm−1 (Figure 4A).
Its intensity increased with time of digestion and the two
additional characteristic (110) and (200) reflections started to be
evolved at q-values of about 1.74 and 2.01 nm−1, respectively,
after about 280 s of lipolysis. At this lipolysis time, the first
order reflection of the coexisting Lα phase started also to
appear at q value of about 1.40 nm−l. Its identification was
based on the appearance of very weak third characteristic
reflection after 2,980 s of lipolysis at q-value of about 4.20
nm−1. Based on the position of the first order reflection that
was clear to identify, the second order peak position at q-
value (∼2.80 nm−1) was calculated and marked in Figure 4.
As shown in Figure 5A, the lattice parameter and d-spacing
of the H2 and Lα phases were about 7.21 ± 0.04 and 4.50
± 0.10 nm, respectively, and were almost not affected with
increasing the lipolysis time up to 2,980 s. In this H2/Lα phase
coexistence regime, the H2 phase became more ordered and
developed with increasing lipolysis time as indicated from the
time evolution of the intensity of its first order diffraction
peak (Figure 5B). However, less time was required for the
coexisting Lα phase to become fully developed as the intensity
of its first order diffraction peak was increased up to ∼910 s
and then reached plateau with increasing further the lipolysis
time (Figure 5B).
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FIGURE 5 | The calculated lattice constants (A) and temporal evolution (B) of the detected inverse hexagonal (H2) and lamellar (Lα) phases during lipolysis of sample
S1 (sodium caseinate-stabilized KO emulsion). The H2 and Lα phases are represented by open red circles and green squares, respectively. For samples S2 and S3,
the calculated lattice constant (C) and temporal evolution (D) of the detected lamellar (Lα) phase during lipolysis are represented by open red and green triangles,
respectively. In (D), the solid blue line shows the best single exponential fit to the data. In (A,C), the lattice constants of the liquid crystalline phases were calculated
from the SAXS profiles presented in Figure 2.
To compare the effect of ω-3 PUFA-containing oil type
on the lipolysis-triggered evolving behavior of lyotropic liquid
crystalline phases in the emulsified emulsion droplets, two
additional sets of time-resolved SAXS experiments were carried
out on AO emulsions stabilized by using sodium caseinate
(sample S2) and citrem (sample S3). As presented in Table 1, AO
exists similar to FO in the form of triacylglycerols; whereas most
of ω-3 PUFAs as mentioned above are bound to phospholipids
in KO. This significant difference between these two oils in
lipid composition, phospholipid content, molecular structure
of ω-3 PUFAs (triacylglycerols as compared to phospholipids)
was reflected in the SAXS profiles presented in Figure 3 for
the three investigated emulsions under identical experimental
conditions. For AO emulsions (samples S2 and S3, Table 2), it
was evident from the SAXS profiles presented in Figures 3B,C
that the associated changes in the lipid composition of the
emulsified AO during lipolysis led to the appearance of a
neat Lα phase. Replacing sodium caseinate with citrem did not
have a significant effect on the kinetics of structure formation.
However, it is important to bear in mind that the replacement
of sodium caseinate and citrem by non-digestible polymeric
stabilizers could lead to a significant decrease in the digestibility
of these emulsions due to restrictions on lipase accessibility to
the oil localized in the droplets’ interiors. In a previous study,
Gudipati et al. (2010) reported on the important role of the
stabilizer adsorption pattern inmodulating the digestibility of FO
emulsions, and showed that the replacement of citrem by non-
digestible polymeric stabilizers is associated with a decrease in the
digestion rate.
The experimental findings in Figures 5C,D provide more
insight into the evolved neat Lα phase in both samples. Similar
to sodium caseinate-stabilized KO emulsion (Figure 5A), the
d-spacing of the Lα phase in samples S2 and S3 was 4.48 ±
0.02 and 4.52 ± 0.10 nm, respectively, and was almost not
affected within the lipolysis periods of 3,010 and 3,410 s,
respectively (Figure 5C). Thus, the replacement of sodium
caseinate by citrem did not induce any significant change in
the d-spacing of the Lα phase. These results indicate that there
is no significant incorporation of sodium caseinate or citrem
into AO during the emulsion preparation and digestion, and
are in contrast with our previous findings on the significant
effect of this emulsifier (citrem) on the structural features
of lamellar and non-lamellar liquid crystalline nanoparticles
based on soybean phospholipid, ω-3 PUFA monoglycerides,
or monoolein (Hedegaard et al., 2013; Azmi et al., 2015, 2016;
Wibroe et al., 2015; Yaghmur et al., 2017; Prajapati et al., 2018;
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Shao et al., 2018). The time evolution of the first order reflection
of the Lα phase and the single exponential function used to
fit the SAXS data (full blue line) are presented in Figure 5D.
The formation of the developed Lα phase in samples S2 and S3
was accomplished after ∼1,500 and 1,250 s, respectively. It is
interesting that the oil type did not have any significant influence
on the d-spacing of the Lα phase in the three investigated
samples (Figures 5A,C). The reason for this similarity in the
d-spacing of the Lα phase in emulsified KO and AO droplets
stabilized either by sodium caseinate or citrem is unclear but
could be attributed to the presence of relatively similar lipid
composition (mainly FFAs) in the lipolysis-triggered Lα phase
in these samples. It is clear that the effects of lipid composition
of KO and AO, and the concentration and type of ω-3 PUFA-
containing lipolysis products on modulating their digestibility
and the associated dynamic structural features warrant
further investigation.
CONCLUSIONS
The lipolysis-induced dynamic phase behavior in emulsions
prepared using two different ω-3 PUFA-containing oils, in
which ω-3 PUFAs exist either in the form of triacylglycerols
(AO) or phospholipids (KO), was compared. In situ SAXS
combined with an in vitro lipolysis model depicted the dynamic
structural features occurring during lipolysis of three KO and AO
emulsions, stabilized using either sodium caseinate or citrem. It
was evident from SAXS findings that the ω-3 PUFA-containing
oil type and its lipid composition play an important role in
modulating the structural properties of the lipolysis-induced
phases. The adsorption of lipase to the outer surfaces of emulsion
droplets that was followed by the digestion of the emulsified
marine oils (KO and AO) triggered fast molecular lipid re-
arrangements and incorporation of the lipolysis products into
their cores. This leads to the generation of internal biphasic
H2/Lα features and neat Lα phases in the digested KO and
AO emulsion droplets, respectively. It is interesting that the
stabilizer type (sodium caseinate vs. citrem) and composition of
KO and AO did not influence the detected Lα phase that had a
d-spacing of about 4.5 nm in the three investigated emulsions.
Table 3 presents our experimental findings. The structural
parameters of lyotropic liquid crystalline phases identified in
digested KO and AO emulsions are given and compared
to those previously reported in digested human breast milk
and mayonnaise.
KO and AO are attractive for the development of functional
food and drug nanocarriers owing to the beneficial health
effects of ω-3 PUFAs, and the important role of lipase-
mediated lipolysis in generating nano-self-assemblies. These
structures may facilitate the transport and delivery of nutrients
and bioactive food additives throughout the body. The
presented findings may have implications for functional food
delivery applications with controllable digestibility, through
an improved understanding of the digestion mechanism and
the role of the evolved self-assembled nanostructures in
modulating digestibility.
TABLE 3 | Structural parameters of lyotropic lamellar and non-lamellar liquid
crystalline phases identified in digested KO and AO emulsions at 37◦C and
selected published findings for digested human breast milk and mayonnaise as
determined from SAXS analysis.
Investigated system Space
group
Lattice parameter, a
(nm)
References
KO-in-water emulsion H2 7.20 Present study
Lα 4.50 ± 0.10
Sodium caseinate
-stabilized
AO-in-water emulsion
Lα 4.48 ± 0.02 Present study
Citrem-stabilized
AO-in-water emulsion
Lα 4.52 ± 0.10 Present study
Human breast milk Fd3m ∼15.3–15.7 (Salentinig et al.,
2015a)
H2 6.50 (Salentinig et al.,
2015a)
Im3m 20.85 (Salentinig et al.,
2015a)
Mayonnaise Fd3m ∼16.50–17.50 (Salentinig et al.,
2017)H2 ∼5.70–7.40
Pn3m ∼24.20–27.90
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